메뉴 건너뛰기




Volumn 24, Issue 2, 2016, Pages 93-97

Understanding cost and value in hepatitis C therapy

Author keywords

Cost effectiveness; Early HCV disease; HCV; HCV therapy; Hepatitis C; HIV; Insurance; Payers

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; EDUCATION PROGRAM; FOLLOW UP; HEALTH CARE COST; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MEDICARE; OUTCOME ASSESSMENT; PHARMACY BENEFIT MANAGER; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE DELIVERY; HEPATITIS C, CHRONIC; TREATMENT OUTCOME;

EID: 84990060411     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (8)
  • 2
    • 0035869435 scopus 로고    scopus 로고
    • The cost effectiveness of combination antiretroviral therapy for HIV disease
    • Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med. 2001;344(11):824-831.
    • (2001) N Engl J Med , vol.344 , Issue.11 , pp. 824-831
    • Freedberg, K.A.1    Losina, E.2    Weinstein, M.C.3
  • 3
    • 60849091364 scopus 로고    scopus 로고
    • Comparing impact and cost-effectiveness of primary prevention strategies for lipidlowering
    • Pletcher MJ, Lazar L, Bibbins-Domingo K, et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipidlowering. Ann Intern Med. 2009;150(4):243-254.
    • (2009) Ann Intern Med , vol.150 , Issue.4 , pp. 243-254
    • Pletcher, M.J.1    Lazar, L.2    Bibbins-Domingo, K.3
  • 4
    • 13444267665 scopus 로고    scopus 로고
    • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy
    • Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-585.
    • (2005) N Engl J Med , vol.352 , Issue.6 , pp. 570-585
    • Sanders, G.D.1    Bayoumi, A.M.2    Sundaram, V.3
  • 5
    • 8544236209 scopus 로고    scopus 로고
    • Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments
    • Hamel MB, Phillips RS, Davis RB, et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med. 1997;127(3):195-202.
    • (1997) Ann Intern Med , vol.127 , Issue.3 , pp. 195-202
    • Hamel, M.B.1    Phillips, R.S.2    Davis, R.B.3
  • 6
    • 84929582795 scopus 로고    scopus 로고
    • Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease
    • Leidner AJ, Chesson HW, Xu F, Ward JW, Spradling PR, Holmberg SD. Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease. Hepatology. 2015;61(6):1860-1869.
    • (2015) Hepatology , vol.61 , Issue.6 , pp. 1860-1869
    • Leidner, A.J.1    Chesson, H.W.2    Xu, F.3    Ward, J.W.4    Spradling, P.R.5    Holmberg, S.D.6
  • 7
    • 84938795806 scopus 로고    scopus 로고
    • Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States
    • Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med. 2015;163(3):215-223.
    • (2015) Ann Intern Med , vol.163 , Issue.3 , pp. 215-223
    • Barua, S.1    Greenwald, R.2    Grebely, J.3    Dore, G.J.4    Swan, T.5    Taylor, L.E.6
  • 8
    • 84924901173 scopus 로고    scopus 로고
    • Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States
    • Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med. 2015;162(6):397-406.
    • (2015) Ann Intern Med , vol.162 , Issue.6 , pp. 397-406
    • Chhatwal, J.1    Kanwal, F.2    Roberts, M.S.3    Dunn, M.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.